Atherosclerosis found in HIV children

Antiretroviral treatment, lipid lowering drugs and prevention with healthy lifestyles are needed to prevent early CVD death in children with HIV

2012-12-05

(Press-News.org) Athens, Greece – 5 December 2012: Children with HIV have a 2.5 fold increased risk of atherosclerosis, according to research1 presented at EUROECHO and other Imaging Modalities 2012. Antiretroviral treatment, lipid lowering drugs and prevention with healthy lifestyles are needed to prevent early death from cardiovascular disease.

EUROECHO and other Imaging Modalities 2012 is the annual meeting of the European Association of Cardiovascular Imaging (EACVI)2, a registered branch of the European Society of Cardiology (ESC)3. It takes place 5-8 December in Athens, Greece, at the Megaron Athens International Conference Centre.

Antiretroviral treatment is prolonging the lives of HIV patients, who no longer die prematurely from the infection. But the treatment is not a cure, and the virus remains in the body. "The infection makes the body fight for its life, so the immune system is always activated and there is chronic inflammation," said Dr Talia Sainz Costa, principal investigator of the study and a paediatrician from Madrid, Spain.

In addition, many antiretroviral drugs increase bad (LDL) cholesterol and lower good (HDL) cholesterol. Dr Sainz Costa said: "Children with HIV will have high cholesterol for a long period and on top of that the virus causes chronic inflammation - both are bad for the arteries."

Patients with HIV die 10 years prematurely from non-AIDS disease which includes cardiovascular diseases, cancer, liver and renal diseases. "This is especially important for children because they have been living with HIV since birth or even before," said Dr Sainz Costa. "By the time they are 50 years old they will have accumulated more toxicity from the treatment and more secondary effects from the infection and will be at an even greater risk of heart attacks and other complications."

The present study aimed to discover whether children and adolescents already have early atherosclerosis damage. Carotid intima-media thickness (IMT), a marker of atherosclerosis, was measured using echocardiography in 150 children and adolescents with HIV and 150 age and sex matched healthy controls.

The researchers found that 17% of the HIV group were smokers compared to 11% of the control group. Dr Sainz Costa said: "Smoking levels in adolescents in Spain are known to be high. The even higher levels in the HIV group are probably related to low socioeconomic status and very complex social/family backgrounds."

After adjustment for age, sex, BMI and smoking status, HIV was independently associated with thicker IMT (p=0.005). Children and adolescents had a 2.5 fold increased risk of higher IMT due to HIV. Dr Sainz Costa said: "Our study shows that children and adolescents with HIV have arteries that are more rigid and less elastic, which means that the process of atherosclerosis has begun and they have increased risk of an infarct in the future."

The researchers also found that frequencies of activated T CD4+ cells were higher among HIV-infected children and young adults (p=0.002). "This shows that the immune system is more active," said Dr Sainz Costa.

They concluded that clinicians need to take cardiovascular prevention more seriously in children and adolescents with HIV, while continuing to treat the HIV infection. Dr Sainz Costa said: "Cardiovascular disease has already put down roots in children and adolescents with HIV and we need to take preventive measures at this early stage. We should be more aggressive in treating their high cholesterol with medication – this practice is common in adults but rare in children."

She added: "We also need to be stricter about healthy lifestyle advice. Many children and adolescents with HIV come from families with low socioeconomic status and are more prone to smoking, poor diet and inactivity. This age group also struggles with adherence to medication which is another worry, but we should not let this decrease our efforts to prevent future complications."

Dr Sainz Costa concluded: "HIV research is investigating ways to control the inflammation and immune activation with agents such as probiotics, aspirin and corticoids. In the meantime clinicians need to focus on ensuring their young patients with HIV take the antiretroviral treatment, take lipid lowering drugs when necessary, and adopt healthier lifestyles."

### Notes to editor

1 Increased subclinical atherosclerosis in HIV-infected children and adolescents – the CaroVIH study (abstract 50254)

2 About the European Association of Cardiovascular Imaging (EACVI) The European Association of Cardiovascular Imaging (EACVI) is a registered branch of the ESC. Its aim is to promote excellence in clinical diagnosis, research, technical development and education in cardiovascular ultrasound and other imaging modalities in Europe. It was formerly called the European Association of Echocardiography (EAE).

3 About the European Society of Cardiology (ESC) The European Society of Cardiology (ESC) represents more than 75,000 cardiology professionals across Europe and the Mediterranean. Its mission is to reduce the burden of cardiovascular disease in Europe.

Information for journalists attending EUROECHO and other Imaging Modalities 2012 EUROECHO and other Imaging Modalities 2012 takes place during 5-8 December in Athens, Greece, at the Megaron Athens International Conference Centre. The full scientific programme is available here http://spo.escardio.org/default.aspx?eevtid=55&hit=highlight-on

Registration is possible onsite, with a valid press card, assignment letter or three bylined articles and signed Embargo form.

A press working area will be available on the exhibition lower level (Level -1). Follow the Speakers Service Centre/Press Working Area signage. There will be no press conference, but a press kit will be available and a press coordinator onsite will assist the media with any EUROECHO and other Imaging Modalities 2012 spokespersons enquiries.

Authors: ESC Press Office
Tel: On site at Athens: +33 6 22 41 84 92
Tel: +33 (0) 4 92 94 8627
Tel: +33 (0) 4 92 94 7756
Email: press@escardio.org END

ELSE PRESS RELEASES FROM THIS DATE:

Treat snoring to avoid deadly heart failure

2012-12-05

Athens, Greece – 5 December 2012: Patients with obstructive sleep apnea have the same early cardiovascular damage as diabetics, according to research presented at EUROECHO and other Imaging Modalities 2012. The study1 was presented by Dr Raluca Mincu from Bucharest, Romania. EUROECHO and other Imaging Modalities 2012 is the annual meeting of the European Association of Cardiovascular Imaging (EACVI)2, a registered branch of the European Society of Cardiology (ESC)3. It takes place 5-8 December in Athens, Greece, at the Megaron Athens International Conference Centre. Obstructive ...

Rejected hearts now viable for transplantation after stress echo

2012-12-05

Athens, Greece – 5 December 2012: Hearts previously rejected due to donors' age or other risk factors can now be declared viable for transplantation using pharmacological stress echo, according to research presented at EUROECHO and other Imaging Modalities 2012. The study1 was presented by Dr Tonino Bombardini from Pisa, Italy. EUROECHO and other Imaging Modalities 2012 is the annual meeting of the European Association of Cardiovascular Imaging (EACVI)2, a registered branch of the European Society of Cardiology (ESC)3. It takes place 5-8 December in Athens, Greece, at ...

Where 'where it's at' is at in the brain

2012-12-05

Conventional wisdom in brain research says that you just used your hippocampus to answer that question, but that might not be the whole story. The context of place depends on not just how you got there, but also the things you see around you. A new study in Neuron provides evidence that a different part of the brain is important for understanding where you are based on the spatial layout of the objects in that place. The finding, in rats, has a direct analogy to primate neuroanatomy. "Understanding how and where context is represented in the brain is important," said ...

Study shows antibody therapy clears Alzheimer's plaques in mice

2012-12-05

Antibodies against amyloid beta (Aβ) protein deposits that are thought to play a role in Alzheimer's disease have shown some success in preventing the buildup of deposits in animals, but they have not been effective at removing preexisting deposits. Now researchers reporting in the December issue of the Cell Press journal Neuron show that a modified antibody was able to clear preexisting Aβ deposits in a mouse model of Alzheimer's disease. "These findings have important implications for current and future development of antibodies for the treatment of Alzheimer's ...

Galaxy-wide echoes from the past

2012-12-05

Many galaxies have a giant black hole at their centre that causes the gas around it to glow. However, in the case of green bean galaxies, the entire galaxy is glowing, not just the centre. These new observations reveal the largest and brightest glowing regions ever found, thought to be powered by central black holes that were formerly very active but are now switching off. Astronomer Mischa Schirmer of the Gemini Observatory had looked at many images of the distant Universe, searching for clusters of galaxies, but when he came across one object in an image from the Canada-France-Hawaii ...

Mayo Clinic: Less invasive surgery detects residual breast cancer in lymph nodes after chemotherapy

2012-12-05

ROCHESTER, Minn. — Most patients whose breast cancer has spread to their lymph nodes have most of the lymph nodes in their armpit area removed after chemotherapy to see if any cancer remains. A study conducted through the American College of Surgeons Oncology Group and led by Judy Boughey, M.D. a breast surgeon at Mayo Clinic shows that a less invasive procedure known as sentinel lymph node surgery successfully identified whether cancer remained in lymph nodes in 91 percent of patients with node-positive breast cancer who received chemotherapy before their surgery. In sentinel ...

Scientists pinpoint great-earthquake hot spots

2012-12-05

"We find that 87% of the 15 largest (8.6 magnitude or higher) and half of the 50 largest (8.4 magnitude or higher) earthquakes of the past century are associated with intersection regions between oceanic fracture zones and subduction zones," says Dietmar Müller, researcher at the University of Sydney in Australia and lead author of the Solid Earth paper. The connection is less striking for smaller earthquakes. Powerful earthquakes related to these intersection regions include the destructive 2011 Tohoku-Oki and 2004 Sumatra events. "If the association we found were ...

URI oceanography student uses crashing waves on shorelines to study Earth's interior

2012-12-05

NARRAGANSETT, R.I. – December 5, 2012 – Scientists have long used the speed of seismic waves traveling through the Earth as a means of learning about the geologic structure beneath the Earth's surface, but the seismic waves they use have typically been generated by earthquakes or man-made explosions. A University of Rhode Island graduate student is using the tiny seismic waves created by ocean waves crashing on shorelines around the world to learn how an underwater plateau was formed 122 million years ago. "There are any number of ways to create seismic waves, but most ...

Wind speeds in southern New England declining inland, remaining steady on coast

2012-12-05

NARRAGANSETT, R.I. – December 5, 2012 – Oceanographers at the University of Rhode Island have analyzed long-term data from several anemometers in southern New England and found that average wind speeds have declined by about 15 percent at inland sites while speeds have remained steady at an offshore site. Kelly Knorr, a graduate student at the URI Graduate School of Oceanography, and Professor John Merrill reported the results of their research today at the fall meeting of the American Geophysical Union in San Francisco. The researchers found that average wind speeds ...

Gladstone scientists: 'ApoE is an ideal target for halting progression of Alzheimer's disease'

2012-12-05

SAN FRANCISCO, CA—December 5, 2012—Despite researchers' best efforts, no drug exists that can slow, halt or reverse the onslaught of Alzheimer's disease. A progressive and fatal neurodegenerative disorder, Alzheimer's has stolen the memories and livelihoods of millions—leaving patients and their families struggling to cope with the disease's devastating consequences. But today, scientists at the Gladstone Institutes propose a new research avenue that has the potential to change all that. In the latest issue of the journal Neuron, available today online, Gladstone Investigators ...

LAST 30 PRESS RELEASES:

New way to find “aged” cells marks fresh approach for research into ageing

From blood sugar to brain relief: GLP-1 therapy slashes migraine frequency

Variability in heart rate during sleep may reveal early signs of stroke, depression or cognitive dysfunction, new study shows

New method to study catalysts could lead to better batteries

Current Molecular Pharmacology impact factor rises to 2.9, achieving Q2 ranking in the Pharmacology & Pharmacy category in 2024 JCR

More time with loved ones for cancer patients spared radiation treatment

New methods speed diagnosis of rare genetic disease

Genetics of cardiomyopathy risk in cancer survivors differ by age of onset

Autism inpatient collection releases genetic, phenotypic data for more than 1,500 children with autism

Targeting fusion protein’s role in childhood leukemia produces striking results

Clear understanding of social connections propels strivers up the social ladder

New research reveals why acute and chronic pain are so different – and what might make pain last

Stable cooling fostered life, rapid warming brought death: scientists use high-resolution fusuline data reveal evolutionary responses to cooling and warming